In another sample of 3800 patients with lung cancer, HER2/neu was positive in only 1.7% of patients (N = 65), all of which had adenocarcinoma and were mainly women, non‐smoker and 50% at Stage IV.12 Here, ERBB2 is linked to lung cancer.